A cytotoxic T lymphocyte (CTL) response to the hepatitis C virus (HCV)
nucleoprotein residues 88-96 that are the minimal and optimal epitope
for human leukocyte antigen (HLA) B44-restricted CTLs was assessed in
27 HLA B44-positive patients with chronic HCV infection. Serum HCV RN
A concentration and the amino acid sequence of the residues 81-100 wer
e also determined. Three patients were infected with HCV with uncommon
amino acid substitutions within the epitope. One was infected with HC
V with an amino acid substitution in the flanking residues of the epit
ope. To stimulate CTLs in the peripheral blood, 9-mer peptides that co
rresponded to the residues 88-96 of the individual patients were synth
esized and used. Seven of the 27 patients demonstrated a CTL response
to the residues 88-96 with specific cytotoxic activities higher than 2
0%. The CTL activities were significantly higher in patients with a lo
w titer of serum HCV RNA than in those with a high titer of serum HCV
RNA (P = .0006). Some of the patients that demonstrated a CTL response
to the residues 88-96 also demonstrated a CTL response to a newly ide
ntified HLA B44-restricted CTL epitope or a known HLA All-restricted C
TL epitope or both. No apparent association was observed between the C
TL response and the stage of disease, or between the CTL response and
the grade of necroinflammatory activity. The results suggest that the
HLA B44-restricted CTLs together with other HCV-specific CTLs may inhi
bit the outgrowth of HCV and that high-titer infection with HCV may su
ppress the CTL responses.